George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Of all stocks to fall today I am surprised about this! If still down tomorrow, intend to double up.
Soon will take past YGEN ...
150K Buy @ 9.45p
I wouldn’t expect many analysts to be decision makers for buying or selling. They’d make a case for an investment hold, buy or sell to their boss or report if shopping for a client. They would also factor in any decisions with macro, health spending and probably do a bit more DD, some may be empowered and ready to go but I’d be surprised, may have a couple of days lag.
Trek
Lousy market today. May end lower!!
2 X Delayed 75k Buys just reported
Don’t worry decent volume today, changing of the guard with a new higher low and soon a higher high. Volume is key with rising sp.
Trek
Delayed 200K Buy just reported
It's a mad world out there, truly. A tiny example of the current craziness is that I could buy at 9.12p after such a strong RNS. The City never ceases to amaze me.
Hope you and yours stay safe and well, dougal....and that goes for everyone else too, by the way.
Suggest a name change to reflect the biz. Goodheart?
In their previous presentation they stressed on two slide that M&A was rife with prices at 4-7x revenue. Slide 5 growth and innovation forum ppt.
So looking back...
LiDCO product revenue up 19% to £7.4m, this is why it’s the first bold line in accounts!
Given there is a recurring revenue element not just one off sales they should command 7x so 51.8m!
But looking forward...
Board expects FY21 Q1 sales will significantly exceed total sales of £3.5m achieved in H1 FY20!
So that is a big lift even against some hospitals not with approved budgets yet and may have to pull back later in the year. That is not clear yet but the outlook and the revenue gives a very strong case for 7x and possibly 8x. £59.2m takeover is possible with more that one bidder.
So looking at 20-25p takeover I reckon
Ps the new ppt is uploaded on website.
Trek
Just topped up with a 22258 buy (which will, no doubt, show as a sell as I paid 9.12p)
Delayed 100K Buy, the first of many. A bit of volume over on Nexechange also
Might even have some of the larger Pharmas in attendance, proven products, low market cap. Definately a takeover target.
The analyst briefing will be with all the institutional investors (including Credit Suisse), we will probably see continuous rises from here on as they add further. Not a lot of freefloat, next update just over a week away and it will mainly be about the global sales due to Covid19
If this ends lower, I shall double up!!
Next update possibly in just over a week
Indeed. Shocked at the slight sell off there.
Got the Analyst briefing at 10:30, followed by the 1630 session.
A news rich few sessions.
Going off this it is going to be nothing but goo news for LID
COVID19 - Let's not forget:
Regulatory approval and successful launch of latest monitor in China
· New exclusive distributors signed in Poland, Saudi Arabia, Chile, Argentina, Mexico & Venezuela
· US Distribution agreement with Xavant
NT to Buy ;)
So draw a line under last year probably only worth 12p and look at the outlook and sales so far. Remember the key is recurring revenues, it’s not a sale and move on it’s a contract as well. Stonking outlook!! Orders from around world, US kicking off a market leading product and contract to outsource clean rooms so no overheads just more revenue!!! Awesome!!
Post year end
· Significant increased demand as a result of COVID-19 with 195 monitors sold to date, predominantly to the UK market, compared with 219 monitors sold in the whole of FY20
· Board expects that sales in the three months ending 30 April 2020 will significantly exceed total sales of £3.5m achieved in H1 FY20
· Registration for latest monitor received in Colombia
· Leases signed for new administration office and manufacturing facility, as well as contract to outsource cleanroom activities.
Trek
Excellent RNS! Great start
I think it’s H1 of last year not the entire year, but still very good...
Very solid last 3 months. Now in profit is great. Makes them an even more attractive target for takeover.
Would love to know more around the NHS engagement and what their disti in the states is up too.
Surely very busy.
Last 3 months have been better than the whole of last year!